Medicina estética infantojuvenil

Voces Expertas

wait, what?

Por la Dra. Vanesa Villamil

Bibliografía:

1. Liew S, Wu WTL, Chan HH, Ho WWS, Kim HJ, Goodman GJ, et al. Consensus on changing trends , attitudes , and concepts of asian beauty. Aesthetic Plast Surg. 2020;44:1186–94.

2. Samizadeh S, Wu W. Ideals of facial beauty amongst the chinese population: results from a large national survey. Aesthetic Plast Surg. 2018;42:1540–50.

3. World Health Organization. Adolescent and young adult health. [Internet]. [Consultado 22 Jul 2023]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/adolescents-health-risks-and-solutions

4. Przylipiak M, Przylipiak J, Terlikowski R, Lubowicka E, Chrostek L, Przylipiak A. Impact of face proportions on face attractiveness. J Cosmet Dermatol. 2018;17:954–9.

5. Ekore RI, Ekore JO. Excoriation (skin-picking) disorder among adolescents and young adults with acne-induced postinflammatory hyperpigmentation and scars. Int J Dermatol. 2021;60:1488–93.

6. Qureshi AA, Stevens WG. Why should young aesthetic plastic surgeons care about aesthetic medicine? Aesthet Surg J. 2019;39:806-10.

7. The American Society for Aesthetic Plastic Surgery. Cosmetic (aesthetic) surgery national data bank statistics. Aesthet Surg J. 2019;39:1-27.

8. Dunlop N, Abramowicz S, Fisher E. Pharmacology of aesthetic medicines. Oral Maxillofac Surg Clin North Am. 2022;34:189–200.

9. Mobayed N, Nguyen JK, Jagdeo J. Minimally invasive facial cosmetic procedures for the millennial aesthetic patient. J Drugs Dermatol. 2020;19:100–3.

10. Bertossi D, Dell´Acqua I, Albanese M, Marchetti P, Nocini P. Face treatment using nonsurgical mini-invasive techniques as postsurgical procedure for traumatic injury. Aesthet Surg J. 2019;39:NP266–78.

11. Taub AF. The treatment of acne scars, a 30 year journey. Am J Clin Dermatol. 2019;20:683-90.

12. Artzi O, Cohen S, Koren A, Niv R, Friedman O. Dual-plane hyaluronic acid treatment for atrophic acne scars. J Cosmet Dermatol. 2020;19:69–74.

13. Goodman GJ, Van Den Broek A. The modified tower vertical filler technique for the treatment of post-acne scarring. Australas J Dermatol. 2016;57:19–23.

14. Rivers CM, Skimming C, Chong D, Drake D, Russell CJH, Devlin MF. Use of hyaluronic acid filler in patients with secondary cleft lip deformity. Cleft Palate Craniofac J. 2023;Mar 5. [Epub ahead of print].

15. Derderian CA. Commentary on: cross-linked hyaluronic acid for cleft lip and palate aesthetic correction: a preliminary report. Aesthet Surg J Open Forum. 2022;18:4.

16. Schweiger ES, Riddle CC, Tonkovic-Capin V, Aires DJ. Successful treatment with injected hyaluronic acid in a patient with lip asymmetry after surgical correction of cleft lip. Dermatol Surg. 2008;34:717–9.

17. Wollina U, Goldman A. Botulinum toxin A and/or soft tissue fillers for facial rehabilitation. Wien Med Wochenschr. 2017;167:92-5.

18. Ordynowski Ł. Cross-linked hyaluronic acid for cleft lip and palate aesthetic correction: a preliminary report. Aesthet Surg J Open Forum. 2022;8:4.

19. Dornelles Manzoni AP, Buss Venier NA. Hyaluronic acid filler correction of scars and asymmetries secondary to cleft lip repair. Dermatol Surg. 2022;48:1264-6.

20. Piggott JR, Yazdani A. Hyaluronic acid used for the correction of nasal deviation in an 18-year-old Middle Eastern man. Can J Plast Surg. 2011;19:156–8.

21. Berros P, Armstrong BK, Foti P, Mancini R. Cosmetic adolescent filler: an innovative treatment of the “selfie” complex. Ophthalmic Plast Reconstr Surg. 2018;34:366–8.

22. Kane MAC. Nonsurgical periorbital and brow rejuvenation. Plast Reconstr Surg. 2015;135:63–71.

23. Pang R, Wang J, Shi J, Zhang H, Bai P. Deep orbital hyaluronic acid gel filler for volume augmentation in orbital dysplasia. J Craniofac Surg. 2022;33:1664–9.

24. Bravo BSF, Totti J, Alcala Gelpi BE, Bianco de Souza S, Gonçalves Bravo L. Use of hyaluronic acid fillers to correct scleral show: a review of technique. J Clin Aesthet Dermatol. 2018;11:38–40.

25. Cicinelli MV, Dave TV, Madhuri BK, Tiple S, Naik MN. Non-surgical management of congenital ichthyosis using hyaluronic acid gel injection. Eur J Ophthalmol. 2020;30:7-10.

26. Bladen JC, Malhotra R. Reporting outcomes of hyaluronic gel filler as a treatment for epiblepharon. Graefes Arch Clin Exp Ophthalmol. 2019;257:2769-73.

27. Afra TP, Vinay K, Razmi T M, Narang T, Dogra S. Hyaluronic acid fillers for correcting midface volume deficit in Barraquer-Simons syndrome. J Cosmet Dermatol. 2019;18:1264–6.

28. Myung Y, Lee YH, Chang H. Surgical correction of progressive hemifacial atrophy with onlay bone graft combined with soft tissue augmentation. J Craniofac Surg. 2012;23:1841–4.

29. Inbal A, Lemelman BT, Millet E, Greensmith A. Tissue expansion using hyaluronic acid filler for single-stage ear reconstruction: a novel concept for difficult areas. Aesthet Surg J. 2017;37:1085–97.

30. Isken T, Gunlemez A, Kara B, Izmirli H, Gercek H. Botulinum toxin for the correction of asymmetric crying facies. Aesthetic Surg J. 2009;29:524–7.

31. Fu KJ, Teichgraeber JF, Greives MR. Botulinum toxin use in pediatric plastic surgery. Ann Plast Surg. 2016;77:577–82.

32. Al-Qattan MM, Al-Shanawani BN, Alshomer F. Botulinum toxin type A: implications in wound healing, facial cutaneous scarring, and cleft lip repair. Ann Saudi Med. 2013;33:482–8.

33. Gassner HG, Brissett AE, Otley CC, Boahene DK, Boggust AJ, Weaver AL, et al. Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study. Mayo Clin Proc. 2006;81:1023–8.

34. Hu L, Zou Y, Chang SJ, Qiu Y, Chen H, Gang M, et al. Effects of botulinum toxin on improving facial surgical scars: a prospective, split-scar, double-blind, randomized controlled trial. Plast Reconstr Surg. 2018;141:646–50.

35. Lee SH, Min HJ, Kim YW, Cheon YW. The efficacy and safety of early postoperative botulinum toxin A injection for facial scars. Aesthetic Plast Surg. 2018;42:530–7.

36. Mohamed NE, Shabaan SN, Raouf AH. Microbotox (mesobotox) versus microneedling as a new therapeutic modality in the treatment of atrophic post-acne scars. J Cosmet Dermatol. 2022;21:6734–41.

37. Sonane J, Sharma RK, John JR, Sharma R. Botulinum toxin for a better scar in cleft lip surgery: a prospective randomized control trial. J Craniofac Surg. 2022;33:198–202.

38. Bartkowska P, Roszak J, Ostrowski H, Komisarek O. Botulinum toxin type A as a novel method of preventing cleft lip scar hypertrophy – a literature review. J Cosmet Dermatol. 2020;19:2188-93.

39. van der Sluis WB, Kornmann NSS, Tan RA, Don Griot JPW, Téot L, Mustoe TA, et al. Other scar types: optimal functional and aesthetic outcome of scarring in cleft patients. En: Cham. Textbook on scar management: state of the art management and emerging technologies. Springer; 2020. p. 51–7.

40. Bartlett SP. No evidence for long-term effectiveness of early osteodistraction in hemifacial microsomia. Plast Reconstr Surg. 2010;125:1567–8.

41. Chang CS, Wallace CG, Hsiao YC, Chang CJ, Chen PKT. Botulinum toxin to improve results in cleft lip repair: a double-blinded, randomized, vehicle-controlled clinical trial. PLoS One. 2014;9:e115690.

42. Tollefson TT, Senders CM, Sykes JM, Byorth PJ. Botulinum toxin to improve results in cleft lip repair. Arch Facial Plast Surg. 2006;8:221–2.

43. Ji Q, Tang J, Hu H, Chen J, Cen Y. Botulinum toxin type A for preventing and treating cleft lip scarring— A systematic review and meta-analysis. J Cosmet Dermatol. 2022;21:2331–7.

44. Lu TC, Bhandari K, Yao CF, Chen PKT. The effect of botulinum toxin A in unilateral cleft lip scar: comparison of results with different sites of injection. Int J Oral Maxillofac Surg. 2022;51:900–5.

45. Alhazmi B, Aldekhayel S. The use of botulinum toxin type A to minimize scarring in cleft lip repair: a literature review. Arch Plast Surg. 2019;46:181–4.

46. Cueva Galárraga IM. Use of botulinum toxin in cheiloplasty: a new method to decrease tension. Can J Plast Surg. 2009;17:1–2.

47. Aizenbud A, Nachmani A, Silberstein E, Rosenberg L. Botulinum toxin injections for modulation of nasal and facial grimaces in a cleft lip and palate patient. Plast Reconstr Surg. 2009;124:170–2.

48. Yin HY, Wang C, Zhang ZY, Shi L, Yin L, Liu W, et al. One-year relapse of mandibular distraction for hemifacial microsomia using masseteric botulinum toxin type A injections. J Craniofac Surg. 2018;29:1737–41.

49. Cho YM, Kim SG, Choi DS, Jang I, Cha BK. Botulinum toxin injection to treat masticatory movement disorder corrected mandibular asymmetry in a growing patient. J Craniofac Surg. 2019;30:1850–4.

50. Pereira Rodrigues AL, Cardoso HJ, Ângelo DF. Patient experience and satisfaction with different temporomandibular joint treatments: A retrospective study. J Craniomaxillofac Surg. 2023;51:44-51.

51. Tamura BM, Lourenço LM, Platt A, Pertel P, Santos LFG, Levites J. Cutis laxa: improvement of facial aesthetics by using botulinum toxin. Dermatol Surg. 2004;30:1518–20.

52. Ashena Z, Webber S. Acquired lateral upper lid entropion in a child treated with botulinum toxin. Eye (Lond). 2012;26:1390–1.

53. Christiansen G, Mohney BG, Baratz KH, Bradley EA. Botulinum toxin for the treatment of congenital entropion. Am J Ophthalmol. 2004;138:153–5.

54. Lindsay RW, Edwards C, Smitson C, Cheney ML, Hadlock TA. A systematic algorithm for the management of lower lip asymmetry. Am J Otolaryngol. 2011;32:1–7.

55. Shokri T, Saadi R, Schaefer EW, Lighthall JG. Trends in the treatment of Bell´s palsy. Facial Plast Surg. 2020;36:628-34.

56. Grassi Salles A, Fernandes da Costa E, Castro Ferreira M, do Nascimento Remigio AF, Borsoi Moraes L, Gemperli R. Epidemiologic overview of synkinesis in 353 patients with longstanding facial paralysis under treatment with botulinum toxin for 11 years. Plast Reconstr Surg. 2015;136:1289–98.

57. Wei LA, Diels J, Lucarelli MJ. Treating buccinator with botulinum toxin in patients with facial synkinesis: a previously overlooked target. Ophthalmic Plast Reconstr Surg. 2016;32:138–41.

58. Sadiq SA, Khwaja S, Saeed SR. Botulinum toxin to improve lower facial symmetry in facial nerve palsy. Eye (Lond). 2012;26:1431–6.

59. Alipour S, Pick C, Jansen S, Rink S, Klußmann JP, Grosheva M. Long-term therapy with botulinum toxin in facial synkinesis: retrospective data analysis of data from 1998 to 2018. Clin Otolaryngol. 2021;46:758–66.

60. Terzis JK, Karypidis D. Therapeutic strategies in post-facial paralysis synkinesis in pediatric patients. J Plast Reconstr Aesthet Surg. 2012;65:1009–18.

61. Haykal S, Arad E, Bagher S, Lai C, Hohman M, Hadlock T. The role of botulinum toxin A in the establishment of symmetry in pediatric paralysis of the lower lip. JAMA Facial Plast Surg. 2015;17:174-8.

62. de Maio M. Therapeutic uses of botulinum toxin: from facial palsy to autonomic disorders. Expert Opin Biol Ther. 2008;8:791–8.

63. Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol. 2000;57:1190–3.

64. Karp BI, Alter K. Botulinum toxin treatment of blepharospasm, orofacial/oromandibular dystonia, and hemifacial spasm. Semin Neurol. 2016;36:84–91.

65. Sabesan T. Meige syndrome: a rare form of cranial dystonia that was treated successfully with botulinum toxin. Br J Oral Maxillofac Surg. 2008;46:588–90.

66. Bandeira ID, Jagersbacher JG, Barretto TL, Vieira Santos C, Lucena R. Botulinum toxin type A in the treatment of facial myotonia in Schwartz-Jampel syndrome. Muscle Nerve. 2017;56:10–1.

67. George SMC, Atkinson LR, Farrant PBJ, Shergill BS. Botulinum toxin for focal hyperhidrosis of the

face. Br J Dermatol. 2014;170:211–3.

68. Glaser DA, Galperin TA. Botulinum toxin for hyperhidrosis of areas other than the axillae and palms/soles. Dermatol Clin. 2014;32:517-25.

69. Baskan EB, Karli N, Baykara M, Cikman S, Tunali S. Localized unilateral hyperhidrosis and neurofibromatosis type 1: case report of a new association. Dermatology. 2005;211:286–9.

70. Corsetti Grazziotin T, Bortoli Buffon R, Dornelles da Silva Manzoni AP, Schafranski Libis A, Blessmann Weber M. Treatment of granulosis rubra nasi with botulinum toxin type A. Dermatol Surg. 2009;35:1298–9.

71. Fabbrocini G, Annunziata MC, D´Arco V, De Vita V, Lodi G, Mauriello MC, et al. Acne scars: pathogenesis, classification and treatment. Dermatol Res Pract. 2010;2010:893080.

72. Vijaya Lakshmi Y, Swetha Reddy L, Neelima Devi KN, Phani Kumar K, Guru Karthik G, Srinivas Chakravarthy P, et al. Evaluation of microneedling therapy in management of facial scars. J Craniofac Surg. 2020;31:214–7.

73. Ebrahim HM, Albalate W. Efficacy of microneedling combined with tacrolimus versus either one alone for vitiligo treatment. J Cosmet Dermatol. 2020;19:855–62.

74. Abdel-Magiud EM, Taha EA, Bakr RM, Ismail SA, Sayed SK, Makboul M, et al. Effects of different therapeutic modalities for postacne scars on circulating collagen III. J Cosmet Dermatol. 2020;19:1517–21.

75. Farrukh AK, Ahmad S, Mehrose MY, Saleem M, Yousaf MA, Mujahid AM, et al. Efficacy of micro-needling on post acne scars. J Ayub Med Coll Abbottabad. 2019;31:336–9.

76. Attwa EM, Khashaba SA, Ezzat NA. Evaluation of the additional effect of topical 5-fluorouracil to needling in the treatment of localized vitiligo. J Cosmet Dermatol. 2020;19:1473–8.

77. Dogra S, Yadav S, Sarangal R. Microneedling for acne scars in asian skin type: an effective low cost treatment modality. J Cosmet Dermatol. 2014;13:180–7.

78. Costa IMC, Costa MC. Microneedling for varicella scars in a dark-skinned teenager. Dermatol Surg. 2014;40:333–4.

79. Alster TS, Li MKY. Microneedling of scars: a large prospective study with long-term follow-up. Plast Reconstr Surg. 2020;145::358–64.

80. Pei D, Chen L, Yao Y, Zeng L, Zhang G. Microneedling combined with compound betamethasone in treatment of severe alopecia areata: a case report. Front Immunol. 2022;13:939077.

81. Moftah NH, El Khayyat MAM, Ragai MH, Alaa H. Carboxytherapy versus skin microneedling in treatment of atrophic postacne scars: a comparative clinical, histopathological, and histometrical study. Dermatol Surg. 2018;44:1332–41.

82. Nobari NN, Tabavar A, Sadeghi S, Dehghani A, Kalantari Y, Ghassemi M, et al. A systematic review of the comparison between needling (RF-needling, meso-needling , and micro-needling) and ablative fractional lasers ( CO2 , erbium YAG) in the treatment of atrophic and hypertrophic scars. Lasers Med Sci. 2023;38:67.

83. Cachafeiro T, Escobar G, Maldonado G, Cestari T, Corleta O. Comparison of nonablative fractional erbium laser 1,340 nm and microneedling for the treatment of atrophic acne scars: a randomized clinical trial. Dermatol Surg. 2016;42:232–41.

84. Ibrahim MK, Ibrahim SM, Salem AM. Skin microneedling plus platelet-rich plasma versus skin microneedling alone in the treatment of atrophic post acne scars: a split face comparative study. J Dermatolog Treat. 2018;29:281-6.

85. Qarqaz FA, Al-yousef A. Skin microneedling for acne scars associated with pigmentation in patients with dark skin. J Cosmet Dermatol. 2018;17:390–5.

86. Alghazzawi M, Almodalal Y. Evaluation of flexibility and thickness of cleft lip scars after treatment with microneedling technique: a cohort trial. Dermatol Pract Concept. 2023;13:e2023083.

87. Kubiak R, Lange B. Percutaneous collagen induction as an additive treatment for scar formation following thermal injuries: preliminary experience in 47 children. Burns. 2017;43:1097–102.

88. Andrade Lima EV, Aandrade Lima MMD, Amante Miot H. Induction of pigmentation through microneedling in stable localized vitiligo patients. Dermatol Surg. 2020;46:434-5.

89. Marasca C, Fabbrocini G, D´Andrea M, Luciano MA, De Maio G, Ruggiero A. Low dose oral corticosteroids, microneedling, and topical 5-fluorouracil: a novel treatment for recalcitrant pediatric vitiligo. Pediatr Dermatol. 2021;38:322-3.

90. Hay RA, Hegazy R, Hady MA, Saleh N. Clinical and dermoscopic evaluation of combined (salicylic acid 20% and azelaic 20%) versus trichloroacetic acid 25% chemical peel in acne: an RCT. J Dermatolog Treat. 2019;30:572-7.

91. Hussein MRA, Ab-Deif EE, Abdel-Motaleb AA, Zedan H, Abdel-Meguid AM. Chemical peeling and microdermabrasion of the skin: comparative immunohistological and ultrastructural studies. J Dermatol Sci. 2008;52:205–9.

92. Sawant O, Khan T. Management of periorbital hyperpigmentation: an overview of nature-based agents and alternative approaches. Dermatol Ther. 2020;33:e13717.

93. Al-Talib H, Al-Khateeb A, Hameed A, Murugaiah C. Efficacy and safety of superficial chemical peeling in treatment of active acne vulgaris. An Bras Dermatol. 2017;92:212–6.

94. Zayed AA, Sobhi RM, El Aguizy RMS, Sabry D, Mahmoud SB. Sequential peeling as a monotherapy for treatment of milder forms of acne vulgaris. J Cosmet Dermatol. 2020;19:1381–7.

95. Perić S, Bubanj M, Bubanj S, Jančić S. Side effects assessment in glicolyc acid peelings in patients with acne type I. Bosn J Basic Med Sci. 2011;11:52–7.

96. Dayal S, Kalra KD, Sahu P. Comparative study of efficacy and safety of 45% mandelic acid versus 30% salicylic acid peels in mild-to-moderate acne vulgaris. J Cosmet Dermatol. 2020;19:393–9.

97. Sun C, Lim D. Chemical peels for atrophic acne scarring: evolution of peel types and methods. Australas J Dermatol. 2023;64:18–27.

98. Dayal S, Amrani A, Sahu P, Jain VK. Jessner’s solution vs. 30% salicylic acid peels: a comparative study of the efficacy and safety in mild-to-moderate acne vulgaris. J Cosmet Dermatol. 2017;16:43–51.

99. Cotellessa C, Manunta T, Ghersetich I, Brazzini B, Peris K. The use of pyruvic acid in the treatment of acne. J Eur Acad Dermatol Venereol. 2004;18:275–8.

100. Szymańska A, Budzisz E, Erkiert-Polguj A. Efficacy of 30% azelaic acid peel in the nonpharmacological treatment of facial acne. J Dermatolog Treat. 2021;32:291–6.

101. Wollina U, Goldman A. Minimally invasive aesthetic procedures in young adults. Clin Cosmet Investig Dermatol. 2011;4:19–26.

102. Al-Waiz MM, Al-Sharqi AI. Medium-depth chemical peels in the treatment of acne scars in dark-skinned Individuals. Dermatol Surg. 2002;28:383–7.

103. Barikbin B, Saadat N, Akbari Z, Yousefi M, Toossi P. Focal high-concentration trichloroacetic acid peeling for treatment of atrophic facial chickenpox scar: an open-label study. Dermatol Surg. 2012;38:1662–7.

104. Karia UK, Padhiar BB, Shah BJ. Evaluation of various therapeutic measures in striae Rubra. J Cutan Aesthet Surg. 2016;9:101–5.

105. Wu WTL, Liew S, Chan HH, Ho WWS, Supapannachart N, Lee HK, et al. Consensus on current injectable treatment strategies in the asian face. Aesthetic Plast Surg. 2020;44:1195–207.

106. Othman S, Cohn JE, Daggumati S, Bloom JD. The impact of dermal fillers on perceived personality traits and attractiveness. Aesthetic Plast Surg. 2021;45:273-80.